Global Antidote Market 2018 Industry Key Players, Trends, Sales, Supply, Demand, Analysis & Forecast 2025

“\”Antidote Market\”” adds “Antidote Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting 2025” reports tits database.

Antidote Market:

Executive Summary

This report studies the global market size of Antidote in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antidote in these regions.

This research report categorizes the global Antidote market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

The use of Antidotes is since the early history of medicine. Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes. Most important development are related to the role of antidotes in the management of poisoning cases that have incurred in past few years. Various studies for instances, toxicodynamic and toxicokinetic is expected to help in improving the approach taken for the development and evaluation of antidotes. In addition due to increasing global concern for the effectiveness of antidotes has resulted in the exchange of knowledge, scientific information and clinical experience between health care professionals and scientists from different parts of the world. The evolution of antidotal therapy has been characterized with the help of new antidotes such as monoclonal antibodies, also by accurate scientific approach for the effectiveness and the complications that may occur, by novel applications of existing pharmaceuticals, and by increased cooperation and collaboration at global level.

Some key factors such as rising awareness and studies that are conducted for development in identifying toxins in venom bites that by government and companies for better knowledge of these drugs and antidotes is likely to drive the growth of antidote market over forecast period. Identification of snakes is highly important so as to know whether it is snake- specific anti-venoms which are less hazardous as compared to polyvalent anti-venoms. However antidote market has some restraints such as low product of anti-venoms due to rising prices of anti-venoms repressed demand resulting the treatment has declined significantly or even disappeared in some areas is expected to hinder the growth of the antidote market.

In 2017, the global Antidote market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Antidote market based on company, product type, application and key regions.

The various contributors involved in the value chain of Antidote include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Antidote include

  • Boehringer Ingelheim Pharmaceuticals
  • AstraZeneca
  • Novartis International
  • Eli Lilly
  • Portola
  • Pfizer
  • Bristol-Myers Squibb
  • Bayer

Market Size Split by Type

  • Chemical Antidotes
  • Physical Antidotes
  • Pharmacological Antidotes
  • Market Size Split by Application
  • Animal Bites
  • Heavy Metal Poisoning
  • Others

The study objectives of this report are:

  • To study and analyze the global Antidote market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
  • To understand the structure of Antidote market by identifying its various subsegments.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • Focuses on the key global Antidote manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Antidote with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To project the value and volume of Antidote submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Antidote are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antidote market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Request Sample Report @

Table of Contents

1 Study Coverage 
1.1 Antidote Product 
1.2 Key Market Segments 
1.3 Key Manufacturers Covered 
1.4 Market by Type 
1.4.1 Global Antidote Market Size Growth Rate by Type 
1.4.2 Chemical Antidotes 
1.4.3 Physical Antidotes 
1.4.4 Pharmacological Antidotes 
1.5 Market by Application 
1.5.1 Global Antidote Market Size Growth Rate by Application 
1.5.2 Animal Bites 
1.5.3 Heavy Metal Poisoning 
1.5.4 Others 
1.6 Study Objectives 
1.7 Years Considered

2 Executive Summary 
2.1 Global Antidote Market Size 
2.1.1 Global Antidote Revenue 2016-2025 
2.1.2 Global Antidote Sales 2016-2025 
2.2 Antidote Growth Rate by Regions 
2.2.1 Global Antidote Sales by Regions 
2.2.2 Global Antidote Revenue by Regions

3 Breakdown Data by Manufacturers 
3.1 Antidote Sales by Manufacturers 
3.1.1 Antidote Sales by Manufacturers 
3.1.2 Antidote Sales Market Share by Manufacturers 
3.1.3 Global Antidote Market Concentration Ratio (CR5 and HHI) 
3.2 Antidote Revenue by Manufacturers 
3.2.1 Antidote Revenue by Manufacturers (2016-2018) 
3.2.2 Antidote Revenue Share by Manufacturers (2016-2018) 
3.3 Antidote Price by Manufacturers 
3.4 Antidote Manufacturing Base Distribution, Product Types 
3.4.1 Antidote Manufacturers Manufacturing Base Distribution, Headquarters 
3.4.2 Manufacturers Antidote Product Category 
3.4.3 Date of International Manufacturers Enter into Antidote Market 
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type 
4.1 Global Antidote Sales by Type 
4.2 Global Antidote Revenue by Type 
4.3 Antidote Price by Type

11 Company Profiles 
11.1 Boehringer Ingelheim Pharmaceuticals 
11.1.1 Boehringer Ingelheim Pharmaceuticals Company Details 
11.1.2 Company Description 
11.1.3 Sales, Revenue and Gross Margin of Antidote 
11.1.4 Antidote Product Description 
11.1.5 Recent Development 
11.2 AstraZeneca 
11.2.1 AstraZeneca Company Details 
11.2.2 Company Description 
11.2.3 Sales, Revenue and Gross Margin of Antidote 
11.2.4 Antidote Product Description 
11.2.5 Recent Development 
11.3 Novartis International 
11.3.1 Novartis International Company Details 
11.3.2 Company Description 
11.3.3 Sales, Revenue and Gross Margin of Antidote 
11.3.4 Antidote Product Description 
11.3.5 Recent Development 
11.4 Eli Lilly 
11.4.1 Eli Lilly Company Details 
11.4.2 Company Description 
11.4.3 Sales, Revenue and Gross Margin of Antidote 
11.4.4 Antidote Product Description 
11.4.5 Recent Development 
11.5 Portola 
11.5.1 Portola Company Details 
11.5.2 Company Description 
11.5.3 Sales, Revenue and Gross Margin of Antidote 
11.5.4 Antidote Product Description 
11.5.5 Recent Development 
11.6 Pfizer 
11.6.1 Pfizer Company Details 
11.6.2 Company Description 
11.6.3 Sales, Revenue and Gross Margin of Antidote 
11.6.4 Antidote Product Description 
11.6.5 Recent Development 
11.7 Bristol-Myers Squibb 
11.7.1 Bristol-Myers Squibb Company Details 
11.7.2 Company Description 
11.7.3 Sales, Revenue and Gross Margin of Antidote 
11.7.4 Antidote Product Description 
11.7.5 Recent Development 
11.8 Bayer 
11.8.1 Bayer Company Details 
11.8.2 Company Description 
11.8.3 Sales, Revenue and Gross Margin of Antidote 
11.8.4 Antidote Product Description 
11.8.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis 
12.1 Market Opportunities and Drivers 
12.2 Market Challenges 
12.3 Market Risks/Restraints 
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis 
13.1 Value Chain Analysis 
13.1.1 Typical Suppliers of Key Antidote Raw Material 
13.1.2 Antidote Customers 
13.2 Sales Channels Analysis 
13.2.1 Sales Channels Analysis 
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix     


For further information on this report, visit –


Media Contact
Company Name:
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India